FEMCET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Femcet, and when can generic versions of Femcet launch?
Femcet is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in FEMCET is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for FEMCET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FEMCET at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FEMCET
US Patents and Regulatory Information for FEMCET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt | FEMCET | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 089102-001 | Jun 19, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |